Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1019.4500 -17.05 (-1.64%)
NSE Jul 07, 2025 15:31 PM
Volume: 184.7K
 

announcement
Conference/Earnings Calls Alerts
1019.45
-1.64%
Conference Call with Suven Pharmaceuticals Management and Analysts to discuss the merger with Cohance Lifesciences and the business outlook for the combined entity. Listen to the full earnings transcript.
Management in attendance: Annaswamy Vaidheesh, Dr. V Prasada Raju, and senior team.
More from Cohance Lifescien…
All earning calls
Investor presentations from Cohance Lifescien…
All investor presentations